EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modified Hemocyanins from Rapana thomasiana and Helix aspersa Exhibit Strong Antitumor Activity in the B16F10 Mouse Melanoma Model

Emiliya Stoyanova, Nikolina Mihaylova iD, Nikola Ralchev iD, Silviya Bradyanova, Iliyan Manoylov iD, Yuliana Raynova, Krassimira Idakieva, Andrey Tchorbanov

Marine Drugs · 2024

DOI: 10.3390/md22100462 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, 2024. Verfasst von Emiliya Stoyanova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Stefan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Melanoma, Experimental, Mice, Inbred C57BL, Antineoplastic Agents, Hemocyanins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bulgarian Science Fund, National science program Young scientists and postdoctoral researchers, the European Fund for regional development through Operational Program Science and Education for Smart Growth 2014 - 2020.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma is one of the most common tumors worldwide, and new approaches and antitumor drugs for therapy are being investigated. Among the promising biomolecules of natural origin for antitumor research are gastropodan hemocyanins—highly immunogenic multimeric glycoproteins used as antitumor agents and components of therapeutic vaccines in human and mouse cancer models. A murine melanoma model established in C57BL/6 mice of the B16F10 cell line was used to study anticancer modified oxidized hemocyanins (Ox-Hcs) that were administered to experimental animals (100 μg/mouse) under different regimens: mild, intensive, and with sensitization. The solid tumor growth, antitumor response, cell infiltration in tumors, and survival were assessed using flow cytometry, ELISA, and cytotoxicity assays. Therapy with Ox-RtH or Ox-HaH resulted in the generation of enhanced specific immune response (increased levels of tumor-infiltrated mature NK cells (CD27+CD11b+) in sensitized groups and of macrophages in the intensively immunized animals) and tumor suppression. Beneficial effects such as delayed tumor incidence and growth as well as prolonged survival of tumor-bearing animals have been observed. High levels of melanoma-specific CTLs that mediate cytotoxic effects on tumor cells; tumor-infiltrating IgM antibodies expected to enhance antibody-dependent cellular cytotoxicity; type M1 macrophages, which stimulate the Th1 response and cytotoxic cells; and proinflammatory cytokines, were also observed after Ox-Hcs administration. The modified Hcs showed strong antitumor properties in different administration regimens in a murine model of melanoma with potential for future application in humans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Melanoma, ExperimentalMice, Inbred C57BLAntineoplastic AgentsHemocyaninsAnimalsMiceCell Line, TumorKiller Cells, NaturalFemaleDisease Models, AnimalSnails

Stichwörter der Autor:innen

C57BL/6 mouse melanoma modelanticancer therapymodified hemocyanins

Substanzen

Antineoplastic AgentsHemocyanins

Autor:innen und Institutionen

  • Department of Immunology, Stefan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
  • Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.

ORCID-Profile: Nikolina Mihaylova, Nikola Ralchev, Iliyan Manoylov

Förderung

  • Bulgarian Science Fund
  • National science program Young scientists and postdoctoral researchers
  • the European Fund for regional development through Operational Program Science and Education for Smart Growth 2014 - 2020
  • National Science Fund, Bulgaria
  • European Fund for regional development through Operational Program Science and Education for Smart Growth 2014–2020

Zitieren

APA

Stoyanova, E., Mihaylova, N., Ralchev, N., Bradyanova, S., Manoylov, I., Raynova, Y., Idakieva, K., & Tchorbanov, A. (2024). Modified Hemocyanins from Rapana thomasiana and Helix aspersa Exhibit Strong Antitumor Activity in the B16F10 Mouse Melanoma Model. Marine Drugs. https://doi.org/10.3390/md22100462

Vancouver

Stoyanova E, Mihaylova N, Ralchev N, Bradyanova S, Manoylov I, Raynova Y, et al. Modified Hemocyanins from Rapana thomasiana and Helix aspersa Exhibit Strong Antitumor Activity in the B16F10 Mouse Melanoma Model. Marine Drugs. 2024. doi:10.3390/md22100462

BibTeX
@article{Stoyanova2024,
  author = {Stoyanova, Emiliya and Mihaylova, Nikolina and Ralchev, Nikola and Bradyanova, Silviya and Manoylov, Iliyan and Raynova, Yuliana and Idakieva, Krassimira and Tchorbanov, Andrey},
  title = {Modified Hemocyanins from Rapana thomasiana and Helix aspersa Exhibit Strong Antitumor Activity in the B16F10 Mouse Melanoma Model},
  journal = {Marine Drugs},
  year = {2024},
  doi = {10.3390/md22100462}
}
Kostenlos starten →